John Hancock Marathon Fund Files 424B3 Prospectus
| Field | Detail |
|---|---|
| Company | John Hancock Marathon Asset-Based Lending Fund |
| Form Type | 424B3 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: prospectus, fund-update, capital-raise
TL;DR
**John Hancock Marathon Fund just updated its prospectus, keeping its offering active.**
AI Summary
John Hancock Marathon Asset-Based Lending Fund filed a 424B3 prospectus on March 24, 2026, related to its registration statement (File No. 333-282371). This filing is a standard update to their offering documents, indicating they are actively raising capital or maintaining their ability to do so. For investors, this means the fund is operational and continues to seek investments in asset-based lending, which could impact its future performance and dividend capacity.
Why It Matters
This filing updates the public offering documents for the John Hancock Marathon Asset-Based Lending Fund, signaling its ongoing capital-raising activities and operational status.
Risk Assessment
Risk Level: low — This is a routine prospectus filing, which generally carries a low direct risk to existing shareholders as it's an administrative update.
Analyst Insight
Investors should view this as a routine administrative update. It confirms the fund's ongoing operations and ability to raise capital, but doesn't signal any immediate change in strategy or performance. Reviewing the full prospectus (d101806d424b3.htm) would provide details on the offering terms.
Key Numbers
- 424B3 — Form Type (Indicates a prospectus filing for a public offering)
- 2026-03-24 — Filing Date (The date the prospectus was filed with the SEC)
- 333-282371 — File No. (The registration statement number this prospectus relates to)
Key Players & Entities
- John Hancock Marathon Asset-Based Lending Fund (company) — the filer of the 424B3 prospectus
- 0001885778 (company) — the CIK of the filer
- 2026-03-24 (date) — the filing date of the 424B3 prospectus
- 333-282371 (dollar_amount) — the File No. for the registration statement
FAQ
What is the purpose of the 424B3 filing by John Hancock Marathon Asset-Based Lending Fund?
The 424B3 filing, dated March 24, 2026, is a prospectus related to the fund's registration statement (File No. 333-282371). It serves to update or finalize the offering documents for securities being offered to the public, allowing the fund to continue raising capital.
When was this specific 424B3 filing accepted by the SEC?
This 424B3 filing was accepted by the SEC on March 24, 2026, at 10:23:26.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 15.3 · Accepted 2026-03-24 10:23:26
Filing Documents
- d101806d424b3.htm (424B3) — 7KB
- g128832jhim_fcv.jpg (GRAPHIC) — 6KB
- 0001193125-26-120975.txt ( ) — 16KB
From the Filing
HANCOCK MARATHON ASSET-BASED LENDING FUND John Hancock Marathon Asset-Based Lending Fund Prospectus Supplement John Hancock Marathon Asset-Based Lending Fund (the fund) Supplement dated March 24, 2026 to the current Prospectus, as may be supplemented (the Prospectus) On January 26, 2026, an affiliate of CVC Capital Partners plc, a private markets investment firm, announced that it has agreed to acquire 100% of Marathon Asset Management, L.P., the fund's subadviser ("Marathon") in a cash and equity transaction (the "Transaction"). The closing of the Transaction will result in a change of control of Marathon, and therefore the current subadvisory agreement between Marathon and John Hancock Investment Management LLC (the "Adviser") with respect to the fund, dated June 15, 2022, will automatically terminate pursuant to Section 15(a)(4) of the Investment Company Act of 1940, as amended (the "1940 Act"), thus requiring approval of a new subadvisory agreement (the "New Subadvisory Agreement") between Marathon and the Adviser. At its meeting held on March 23, 2026, the Board of Trustees (the "Board" or the "Trustees") of the fund, a closed-end fund operating as a tender offer fund, including, as applicable, a majority of the Trustees who are not "interested persons" of the fund, as defined under the 1940 Act, considered and approved: (1) the election of three (3) Trustees as members of the Board (the "Election"); (2) the New Subadvisory Agreement between Marathon and the Advisor; and (3) other related changes. The Board's approval of the Election and the New Subadvisory Agreement, are subject to the approval of the fund's shareholders ("Shareholders"). Accordingly, at an upcoming special meeting of Shareholders to be held on June 18, 2026 (the "Shareholder Meeting"), including any adjournment or postponement thereof, Shareholders will be asked to approve: (1) the Election; and (2) the New Subadvisory Agreement (together, the "Proposals"). Shareholders will not be asked to approve any other changes. More detailed information about the Proposals to be voted on at the Shareholder Meeting will be provided in a forthcoming proxy statement on or about May 7, 2026. When you receive your proxy statement, please review it carefully and cast your vote to avoid the additional expense to the fund of any future solicitations. This Supplement is not a proxy and is not soliciting any proxy, which can only be done by means of a proxy statement. You should read this supplement in conjunction with the Prospectus and retain it for your future reference. Manulife, Manulife Investments, Stylized M Design, and Manulife Investments & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and John Hancock, and the Stylized John Hancock Design are trademarks of John Hancock Life Insurance Company (U.S.A.). Each are used by it and by its affiliates under license.